Northern Trust
ADIL

Northern Trust’s Adial Pharmaceuticals ADIL Stock Holding History

Northern Trust’s Portfolio ADIL Stock Details ADIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,639
Closed -$14.5K – 4398
2025
Q4 		$14.5K Buy
+2,639
New +$21.4K ﹤0.01% 4416
2023
Q3 		– Sell
-48
Closed -$6.18K – 4463
2023
Q2 		$6.18K Hold
48
– – ﹤0.01% 4501
2023
Q1 		$10.4K Hold
48
– – ﹤0.01% 4521
2022
Q4 		$6.39K Hold
48
– – ﹤0.01% 4615
2022
Q3 		$10K Hold
48
– – ﹤0.01% 4638
2022
Q2 		$40K Buy
48
+1
+2% +$906 ﹤0.01% 4467
2022
Q1 		$59K Hold
47
– – ﹤0.01% 4497
2021
Q4 		$79K Hold
47
– – ﹤0.01% 4486
2021
Q3 		$126K Buy
47
+12
+34% +$25.1K ﹤0.01% 4338
2021
Q2 		$56K Buy
+35
New +$53.2K ﹤0.01% 4474
2020
Q4 		– Sell
-19
Closed -$27K – 4375
2020
Q3 		$27K Buy
+19
New +$17.7K ﹤0.01% 4173

Other funds holding ADIL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MCM
Manchester Capital Management Manchester, Vermont $694M AUM 22.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return

Northern Trust's ADIL Position: Q1 2026 in Review

Northern Trust sold out of Adial Pharmaceuticals (ADIL) in Q1 2026, closing a stake of 2,639 shares — an estimated $14.5K sold.

Northern Trust first reported a position in ADIL in Q3 2020 and held it in 11 quarters. The position peaked at $126K in Q3 2021. 14 funds tracked by Wall St. Rank hold ADIL as of Q1 2026.

  • Northern Trust reported no remaining Adial Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Northern Trust sold 2,639 Adial Pharmaceuticals shares in Q1 2026, an estimated $14.5K.
  • Northern Trust first reported a position in Adial Pharmaceuticals in Q3 2020 and held it in 11 quarters.
  • Northern Trust's Adial Pharmaceuticals position peaked at $126K in Q3 2021.
  • 14 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.